Related Experiment Video
Updated: Jul 12, 2025

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
Cachexia and head and neck squamous cell carcinoma: A scoping review
1UCL Eastman Dental Institute, London, UK.
Oral Diseases
|October 27, 2023
Summary
Cachexia is common in head and neck cancer, causing significant tissue loss. While interventions can help, cachexia in oral squamous cell carcinoma indicates a poor prognosis for patients.
Area of Science:
- Oral Health
- Oncology
- Metabolic Disorders
Background:
- Cachexia is a complex metabolic syndrome associated with inflammation and negative energy balance.
- It significantly impacts patients with advanced cancers, particularly head and neck malignancies.
- Oral health care providers play a crucial role in identifying and managing cachexia in this patient population.
Purpose of the Study:
- To review and understand cachexia in the context of oral squamous cell carcinoma (OSCC).
- To explore the clinical presentation, etiology, and management of cachexia relevant to oral health.
- To enhance the understanding for oral health care professionals regarding cachexia in OSCC patients.
Main Methods:
- A scoping review methodology was employed.
- Searches were conducted in MEDLINE and EMBASE databases (2000-2023).
- Inclusion criteria focused on head and neck/oral squamous cell carcinoma and cachexia in human studies.
Main Results:
- Cachexia is a frequent complication in advanced head and neck cancers.
- Multiple mechanisms, including tumor-induced factors, contribute to cachexia.
- These mechanisms lead to reduced nutritional intake, increased metabolism, and loss of muscle and fat tissue.
Conclusions:
- Cachexia in head and neck cancer is driven by complex, tumor-related factors.
- Interventions can improve quality of life and survival duration.
- However, cachexia diagnosis in OSCC remains a marker of poor life expectancy.
Related Concept Videos
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

